The changing epidemiology of pediatric endocarditis at a children's hospital over seven decades
Related Experiment Video
Updated: Jun 13, 2026

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
Published on: January 7, 2019
Lauren B Rosenthal1, Kristina N Feja, Stéphanie M Levasseur
1Morgan Stanley Children's Hospital of NewYork-Presbyterian, New York, NY, USA.
Insights
Improvements in pediatric cardiac care have shifted infective endocarditis (IE) epidemiology. IE now affects younger children with congenital heart disease (CHD), with hospital-acquired infections driving mortality.
Area of Science:
- Pediatric Cardiology
- Infectious Diseases
- Epidemiology
Background:
- Congenital heart disease (CHD) care has advanced significantly.
- Infective endocarditis (IE) is a serious complication in pediatric patients.
- Understanding IE epidemiology in CHD is crucial for improving outcomes.
Purpose of the Study:
- To investigate changes in the epidemiology of infective endocarditis (IE) in children.
- To compare IE trends in pediatric patients over three distinct time periods.
- To assess the impact of improved cardiac care on IE in children with CHD.
Main Methods:
- Retrospective analysis of pediatric IE cases (1930-2004).
- Comparison of three eras: 1930-1959, 1977-1992, and 1992-2004.
- Inclusion of patients aged 18 years or younger.
Main Results:
- Median age of IE diagnosis decreased from 8 years (eras 1 & 2) to 1.5 years (era 3).
- Increased incidence of non-streptococcal, non-staphylococcal pathogens in hospital-acquired IE (era 3).
- Mortality in era 3 was confined to hospital-acquired IE cases.
Conclusions:
- Pediatric IE epidemiology has evolved, now primarily affecting young children with complex CHD.
- While overall complications decreased, hospital-acquired IE remains a significant mortality risk.
- Modern IE management requires focus on preventing hospital-acquired infections in vulnerable pediatric populations.
Abstract:
This study sought to determine whether improvements in the care of children with congenital heart disease (CHD) have changed the epidemiology of infective endocarditis (IE). A retrospective study of patients 18 years of age and younger treated for IE from 1992 to 2004 (era 3) was conducted at the authors' children's hospital in New York City. This study was compared with two previous studies conducted at the same hospital from 1930 to 1959 (era 1) and from 1977 to 1992 (era 2). During the three eras, IE was diagnosed for 205 children with a median age of 8 years during eras 1 and 2, which decreased to 1.5 years during era 3, partly because of IE after cardiac surgery for young infants. In era 3, nonstreptococcal and nonstaphylococcal pathogens associated with hospital-acquired IE increased. Complications from IE declined during era 3, but after the widespread availability of antibiotics in 1944, crude mortality rates were similar in eras 1 (32%), 2 (21%), and 3 (24%). However, in era 3, mortality occurred only among subjects with hospital-acquired IE. The epidemiology of pediatric IE has changed in the modern era. Currently, IE is most likely to occur among young children with complex congenital heart disease. Pediatric IE remains associated with high crude mortality rates when it is acquired in the hospital.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Rheumatic Heart Disease I: Introduction
Pharmacokinetics in Pediatric Patients: Drug Metabolism